382

Compound name
Lapatinib
Alt Name
Tykerb
Tyverb
Compound Image
Lapatinib.png
SMILES
CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
Brutto
C29H26ClFN4O4S
InChI
InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)
InChI Key
BCFGMOOMADDAQU-UHFFFAOYSA-N
Approval Jurisdiction
2007 FDA
Approved for clinical use
Breast Cancer
CAS
388082-78-8
PubChem CID
208908
Action
EGFR, ERBB2
Approved Drug List
1
Commercial Vendor
GSK